WALTHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Rocket Software, a global technology leader in modernization software, today announced it has entered into a definitive agreement to acquire the ...
Percona recently announced OpenEverest, an open-source platform for automated database provisioning and management that ...
Scientists at Google DeepMind —the company’s artificial intelligence research arm—say they’ve created an A.I. tool that can ...
AI-powered medical wearables and software are flourishing following the FDA’s new hands-off regulatory guidance.
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong preliminary fourth-quarter ...
DexCom, incorporated in Delaware and headquartered in San Diego, California, designs, manufactures, and markets continuous glucose monitoring (CGM) systems to help individuals with types 1 and 2 ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Dexcom recalled an Android app for its G6 continuous glucose monitor because of a problem with the app stopping unexpectedly. This story was originally published on MedTech Dive. To receive daily news ...
Oct 30 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results